Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi ExchangeTotal Valuation
Saudi Pharmaceutical Industries and Medical Appliances Corporation carries a market capitalization of 3.51B, placing it among publicly traded companies globally. Its enterprise value stands at 4.72B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.51B |
| Enterprise Value | 4.72B |
Share Statistics
Saudi Pharmaceutical Industries and Medical Appliances Corporation currently has 119.36M shares outstanding.
| Shares Outstanding | 119.36M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Saudi Pharmaceutical Industries and Medical Appliances Corporation trades at a trailing price-to-earnings ratio of 20.25. The price-to-sales ratio is 2.20, and the price-to-book ratio stands at 2.69.
| PE Ratio | 20.25 |
| PS Ratio | 2.20 |
| PB Ratio | 2.69 |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | 7.90 |
| P/OCF Ratio | 9.90 |
Enterprise Valuation
On an enterprise value basis, Saudi Pharmaceutical Industries and Medical Appliances Corporation trades at an EV/EBITDA multiple of 17.30 and an EV/FCF ratio of 8.72. The EV/Sales ratio of 2.87 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.30 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.87 |
| EV / EBITDA | 17.30 |
| EV / EBIT | 17.30 |
| EV / FCF | 8.72 |
Financial Position
Saudi Pharmaceutical Industries and Medical Appliances Corporation maintains a current ratio of 1.26, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 69.61, indicating elevated leverage, while an interest coverage ratio of 2.92 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.26 |
| Quick Ratio | 0.19 |
| Debt / Equity | 69.61 |
| Debt / EBITDA | 4.67 |
| Interest Coverage | 2.92 |
Financial Efficiency
Saudi Pharmaceutical Industries and Medical Appliances Corporation posts a return on equity of 14.32 and a return on invested capital of 8.02.
| Return on Equity (ROE) | 14.32 |
| Return on Assets (ROA) | 4.08 |
| Return on Invested Capital (ROIC) | 8.02 |
| Return on Capital Employed (ROCE) | 8.85 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.34 |
Taxes
Over the trailing twelve months, Saudi Pharmaceutical Industries and Medical Appliances Corporation has paid 23.08M in income taxes, reflecting an effective tax rate of 10.84.
| Income Tax | 23.08M |
| Effective Tax Rate | 10.84 |
Stock Price Statistics
Saudi Pharmaceutical Industries and Medical Appliances Corporation's stock has gained approximately 11.78707% over the past 52 weeks. The 50-day moving average sits at 29.24, while the 200-day moving average is 28.92.
| Beta (5Y) | N/A |
| 52-Week Price Change | 11.78707% |
| 50-Day Moving Average | 29.24 |
| 200-Day Moving Average | 28.92 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Saudi Pharmaceutical Industries and Medical Appliances Corporation generated 1.65B in revenue and converted that into 178.61M in net income, yielding earnings per share of 1.60. EBITDA reached 272.77M, while operating income came in at 272.77M.
| Revenue | 1.65B |
| Gross Profit | 839.77M |
| Operating Income | 272.77M |
| Pretax Income | 212.98M |
| Net Income | 178.61M |
| EBITDA | 272.77M |
| EBIT | 272.77M |
| Earnings Per Share (EPS) | 1.60 |
Balance Sheet
Saudi Pharmaceutical Industries and Medical Appliances Corporation holds 341.60M in cash and equivalents against 1.27B in total debt, resulting in a net debt position of 1.12B. Total book value stands at 1.34B, with working capital of 470.86M providing operational flexibility.
| Cash & Cash Equivalents | 341.60M |
| Total Debt | 1.27B |
| Net Debt | 1.12B |
| Equity (Book Value) | 1.34B |
| Book Value Per Share | 11.32 |
| Working Capital | 470.86M |
Cash Flow
Saudi Pharmaceutical Industries and Medical Appliances Corporation produced 365.28M in operating cash flow over the past twelve months. After subtracting -92.87M in capital expenditures, free cash flow totaled 272.41M - equivalent to 2.29 per share.
| Operating Cash Flow | 365.28M |
| Capital Expenditures | -92.87M |
| Free Cash Flow | 272.41M |
| FCF Per Share | 2.29 |
Margins
Saudi Pharmaceutical Industries and Medical Appliances Corporation operates with a gross margin of 51.03, reflecting its pricing power and cost economics. The operating margin of 16.57 and net profit margin of 10.85 provide insight into operational efficiency.
| Gross Margin | 51.03 |
| Operating Margin | 16.57 |
| Pretax Margin | 12.94 |
| Profit Margin | 10.85 |
| EBITDA Margin | 16.57 |
Dividends & Yields
The company's payout ratio of 0.11 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.00 |
| Dividend Yield | N/A |
| Payout Ratio | 0.11 |
| Shareholder Yield | 7.99 |
| FCF Yield | 12.67 |
Stock Splits
Saudi Pharmaceutical Industries and Medical Appliances Corporation's most recent stock split took place on April 20, 2014 with a 5000:7649 split ratio.
| Last Split Date | 4/20/2014 |
| Split Ratio | 5000:7649 |
Scores
Saudi Pharmaceutical Industries and Medical Appliances Corporation posts an Altman Z-Score of 1.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.68 |